Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FRACTYL HEALTH, INC.GUTS · Entity 6700 | Director | June 10, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FRACTYL HEALTH, INC.
Report date June 10, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.73 · Expires 2036-06-09 | Direct | 22,500 |
Reported balance
After 2026-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 22,500 · Balance 22,500 F1: The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 11, 2026 21:03 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option · Derivative | 22,500 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001193125-26-267849 · ownership.xml · derivative · entry 1 Conaway Samuel · CIK 0002007319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2036-06-09 F1 · derivative.exercise_date: The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:05 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option · Derivative | 22,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0000950170-25-086149 · ownership.xml · derivative · entry 1 Conaway Samuel · CIK 0002007319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2035-06-10 F1 · derivative.exercise_date: The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 18:56 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | PurchaseCommon Stock | 8,550 | $1.17 | $9,964.17 |
DisclosureSEC source: 0000950170-25-040138 · ownership.xml · nonDerivative · entry 1 Conaway Samuel · CIK 0002007319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,550 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from 1.165 to 1.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 22:07 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option · Derivative | 45,000 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011331 · ownership.xml · derivative · entry 1 Conaway Samuel · CIK 0002007319 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-01-31 F1 · derivative.exercise_date: The stock option vests in three annual installments beginning on February 1, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.